Infection Caused by Nocardia farcinica: Case Report and Review

被引:0
|
作者
O. H. Torres
P. Domingo
R. Pericas
P. Boiron
J. A. Montiel
G. Vázquez
机构
[1] Department of Internal Medicine (Infectious Diseases Unit),
[2] Hospital de la Santa Creu i Sant Pau,undefined
[3] Autonomous University of Barcelona,undefined
[4] Avinguda,undefined
[5] Sant Antoni Ma Claret 167,undefined
[6] 08025 Barcelona,undefined
[7] Spain e-mail: pere.domingo@cc.uab.es,undefined
[8] Department of Microbiology,undefined
[9] Hospital de la Santa Creu i Sant Pau,undefined
[10] Autonomous University of Barcelona,undefined
[11] Avinguda,undefined
[12] Sant Antoni Ma Claret 167,undefined
[13] 08025 Barcelona,undefined
[14] Spain,undefined
[15] Laboratoire de Mycologie Fondamentale,undefined
[16] et Appliquée aux Biotechnologies Industrielles,undefined
[17] Faculté de Pharmacie,undefined
[18] Institut des Sciences Pharmaceutiques et Biologiques,undefined
[19] 8,undefined
[20] Avenue Rockefeller,undefined
[21] 69373 Lyon Cedex 08,undefined
[22] France,undefined
关键词
Antibiotic Therapy; Wound Infection; Cephalosporin; Underlying Disease; Antimicrobial Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
 Nocardia farcinica is a rare Nocardia species causing localised and disseminated infections. A case of Nocardia farcinica infection is presented, and 52 cases previously reported in the literature are reviewed. The hosts usually had predisposing conditions (85%), and acquired the infection through the respiratory tract or skin; the infection then often spread to the brain, kidney, joints, bones and eyes. Pulmonary or pleural infections (43%), brain abscesses (30%) and wound infections (15%) which failed to respond to conventional antimicrobial therapy were the more frequent forms of infection. Nocardia farcinica was frequently isolated from pus (100% of samples), bronchial secretions (41%) and biopsy specimens (63%), but isolation from blood and urine, as in the case presented here, is rare. Antibiotic therapy was adequate in 61% of the patients in whom it was specified, the agents most frequently given being trimethoprim-sulfamethoxazole (54%), amikacin combined with imipenem (7%) and amoxicillin-clavulanate (7%). The high mortality (31%) can be attributed to the severe underlying diseases present, difficulties encountered in identifying the pathogen, inappropriate therapy and late initiation of therapy. Although an infrequent pathogen, Nocardia farcinica should be kept in mind as a cause of infection especially in immunosuppressed patients with indolent infections not responding to third-generation cephalosporins.
引用
收藏
页码:205 / 212
页数:7
相关论文
共 50 条
  • [21] Pleural Infection Caused by Nocardia farcinica: Two Cases and Review of the Literature
    Bagueste, Graciella
    Porcel, Jose M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [24] Mixed infection of Nocardia farcinica and Nocardia cyriacigeorgica in an immunocompromised patient: A case report
    Thakar, Vrushali Harsh
    Jadhav, Prajakta
    Babu, Aishwarya
    Kumar, Mahadevan
    Mane, Abhijeet Kantilal
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2024, 17 (11) : 516 - 518
  • [25] A CASE OF LUNG INFECTION CAUSED BY AN UNUSUAL STRAIN OF NOCARDIA-FARCINICA
    TSUKAMURA, M
    SHIMOIDE, H
    KANEDA, K
    SAKAI, R
    SEINO, A
    MICROBIOLOGY AND IMMUNOLOGY, 1988, 32 (05) : 541 - 546
  • [26] Successful treatment of pulmonary Nocardia farcinica infection with linezolid: case report and literature review
    Shen, Tian
    Wu, Lihua
    Geng, Lei
    Wei, Zeqing
    Zheng, Shusen
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 15 (05): : 486 - 489
  • [27] CUTANEOUS NOCARDIA-FARCINICA INFECTION IN A NONIMMUNOCOMPROMISED PATIENT - CASE-REPORT AND REVIEW
    SCHIFF, TA
    MCNEIL, MM
    BROWN, JM
    CLINICAL INFECTIOUS DISEASES, 1993, 16 (06) : 756 - 760
  • [28] Membranous Nephropathy Complicated with Disseminated Nocardia farcinica Infection: A Case Report and Literature Review
    Pan, Lei
    Wang, Xu-Hao
    Meng, Fan-Qi
    Su, Xin-Ming
    Li, Yue
    Xu, Ming-Tao
    Su, Feng-yuan
    Kong, De-Lei
    Wang, Wei
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 4157 - 4166